Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Cash & Current Investments (2009 - 2026)

Updated

Abeona Therapeutics (ABEO) reported Cash & Current Investments of $134.94 million for Q3 2026, down 34.8% from $207.12 million a year earlier and down 8.1% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Abeona Therapeutics posted Cash & Current Investments of $191.4 million, up 95.1% from FY2024.

  • Cash & Current Investments has increased for four consecutive years, with a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $98.1 million in FY2024 (+86.5%), $52.6 million in FY2023 (+0.2%), $52.5 million in FY2022 (+3.1%) and $50.9 million in FY2021 (-46.4%).
  • The Q3 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q1 2025.
  • Year over year, Cash & Current Investments gained in six of the last eight quarters, with growth averaging 52.2%.
  • The high point for year-over-year Cash & Current Investments in five years was Q2 2024 (growth of 231.5%); the low point was Q2 2022 (a decline of 66.5%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $146.83 million (Q2 2026), $168.27 million (Q1 2026) and $191.4 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.23 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 505.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.96 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 14.27 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn 134.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 134.94 Mn
Jun 30, 2026 146.83 Mn
Mar 31, 2026 168.27 Mn
Dec 31, 2025 191.40 Mn
Sep 30, 2025 207.12 Mn
Jun 30, 2025 225.52 Mn
Mar 31, 2025 84.50 Mn
Dec 31, 2024 98.10 Mn
Sep 30, 2024 110.00 Mn
Jun 30, 2024 123.00 Mn
Mar 31, 2024 62.70 Mn
Dec 31, 2023 52.60 Mn
Sep 30, 2023 54.10 Mn
Jun 30, 2023 37.10 Mn
Mar 31, 2023 40.70 Mn
Dec 31, 2022 52.50 Mn
Sep 30, 2022 23.50 Mn
Jun 30, 2022 26.00 Mn
Mar 31, 2022 37.20 Mn
Dec 31, 2021 50.90 Mn
API Access

Abeona Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABEO&period=max&api_key=YOUR_API_KEY